These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2649011

  • 1. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB, Roenigk HH, Caro WA, Magid ML.
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [Abstract] [Full Text] [Related]

  • 2. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS.
    Blood Cells; 1992 Apr; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [Abstract] [Full Text] [Related]

  • 3. Skin carcinomas and treatment with photochemotherapy (PUVA).
    Lindskov R.
    Acta Derm Venereol; 1983 Apr; 63(3):223-6. PubMed ID: 6192635
    [Abstract] [Full Text] [Related]

  • 4. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A, Matsunami E, Yamamoto K, Kitajima S, Mizuno N.
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
    [Abstract] [Full Text] [Related]

  • 5. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS, PUVA Follow-Up Study.
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [Abstract] [Full Text] [Related]

  • 6. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL.
    N Engl J Med; 1984 May 03; 310(18):1156-61. PubMed ID: 6709010
    [Abstract] [Full Text] [Related]

  • 7. PUVA treatment and skin cancer: A follow-up study.
    Lassus A, Reunala T, Idänpää-Heikkilä J, Juvakoski T, Salo O.
    Acta Derm Venereol; 1981 May 03; 61(2):141-5. PubMed ID: 6165190
    [Abstract] [Full Text] [Related]

  • 8. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients.
    Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H.
    Dermatology; 1996 May 03; 193(3):185-91. PubMed ID: 8944338
    [Abstract] [Full Text] [Related]

  • 9. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK, Thune P.
    Tidsskr Nor Laegeforen; 1993 Jan 20; 113(2):200-1. PubMed ID: 8430401
    [Abstract] [Full Text] [Related]

  • 10. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients.
    Slaper H, Schothorst AA, van der Leun JC.
    Photodermatol; 1986 Oct 20; 3(5):271-83. PubMed ID: 3822871
    [Abstract] [Full Text] [Related]

  • 11. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG, Wilson LD, Braverman IM, Feldman AM, Kacinski BM.
    Arch Dermatol; 1995 Apr 20; 131(4):432-5. PubMed ID: 7726585
    [Abstract] [Full Text] [Related]

  • 12. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS.
    Br J Dermatol; 2008 Sep 20; 159(4):931-5. PubMed ID: 18834483
    [Abstract] [Full Text] [Related]

  • 13. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA.
    Eskelinen A, Halme K, Lassus A, Idänpään-Heikkilä J.
    Photodermatol; 1985 Feb 20; 2(1):10-4. PubMed ID: 3982991
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B, Fischer T, Michaëlsson G, Norén P.
    Photodermatol; 1984 Feb 20; 1(1):18-22. PubMed ID: 6531278
    [Abstract] [Full Text] [Related]

  • 15. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS, Bagheri S, Nichols K, PUVA Follow Up Study.
    J Am Acad Dermatol; 2002 Jul 20; 47(1):33-9. PubMed ID: 12077578
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB, Piaserico S, Caforio AL, Abeni D, Alaibac M, Angelini A, Iliceto S, Peserico A.
    Arch Dermatol; 2004 Sep 20; 140(9):1079-85. PubMed ID: 15381547
    [Abstract] [Full Text] [Related]

  • 17. Biological amplification factor for sunlight-induced nonmelanoma skin cancer at high latitudes.
    Moan J, Dahlback A, Henriksen T, Magnus K.
    Cancer Res; 1989 Sep 15; 49(18):5207-12. PubMed ID: 2766289
    [Abstract] [Full Text] [Related]

  • 18. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
    Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB.
    N Engl J Med; 1979 Apr 12; 300(15):809-13. PubMed ID: 423919
    [Abstract] [Full Text] [Related]

  • 19. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
    Buckley DA, Rogers S.
    Clin Exp Dermatol; 1996 Jan 12; 21(1):43-5. PubMed ID: 8689768
    [Abstract] [Full Text] [Related]

  • 20. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.
    Cancer Epidemiol Biomarkers Prev; 1998 Feb 12; 7(2):157-61. PubMed ID: 9488591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.